Chimerix

CMX001 Publications & Presentations

2011

CMX001 Was Well Tolerated & Without Nephrotoxicity in Renal Stem Cell Transplant Recipients with BKV

   

V. Ram Peddi, Michael Boeckh, Steven A. Pergam, Eileen Scigliano, Deborah B. Adey, Daniel C. Brennan, Susan Godkin, Alice T. Robertson and Wendy Painter

American Society of Nephrology Kidney Week 2011
November 8-13, 2011
Philadelphia, PA

CMX001 is Not Nephrotoxic or Myelosuppressive in 183 Patients with Life Threatening dsDNA Infections

   

G Papanicolaou, J Kurtzberg, M Grimley, GA Storch, R Goyal, M Anderson, H Mommeja-Marin, W Painter

51st ICAAC
September 18, 2011
Chicago, IL

Experience with CMX001, A Novel Antiviral Drug for CMV Infections in Stem Cell Transplant Patients

   

Genovefa Papanicolaou, MD, Joanne Kurtzberg, MD, Peter Westervelt, MD, Juan Gea-Banacloche, MD, Erica Warlick, MD, Randall Lanier, PhD, Maggie Anderson, and Wendy Painter, MD, MPH2011

2011 BMT Tandem Meeting
February 17-21
Honolulu, Hawaii

2010

A case of progressive mulitfocal leukoencephalopathy and idiopathic CD4 + lymphocytopenia

   

Amila Patel, Julie Patel and Judy Ikwuagwu

Journal of Antimicrobial Chemotherapy Advanced Access
published September 23, 2010

CMX001 & CMX157 Are Not Substrates of Human Organic Anion Transporters hOAT1 and hOAT3

   

TK Tippin, BM Lampert, GR Painter and ER Lanier

FIP Pharmaceutical Sciences
World Congress and AAPS Meeting
November 16, 2010
New Orleans, LA

Compromised Renal Function Doesn’t Affect PK of CMX001 in Patients with Severe dsDNA Virus Infection

   

LC Trost, TK Tippin, MT Anderson and WP Painter

50th ICAAC Annual Meeting
September 12-15, 2010
Boston, MA

2009

Interspecies Comparison of the Pharmacokinetics of CMX001. . .

   

LC Trost, BM Lampert, AT Robertson, S Godkin, W Painter, M Anderson, GR Painter and N Frazer

49th ICAAC Annual Meeting
September 12-15, 2009
San Fransisco, CA

2008

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a . . .

   

Karoly Toth, Jacqueline F. Spencer, Debanjan Dhar, John E. Sagartz, R. Mark L. Buller, George R. Painter, and William S. M. Wold

Proceedings of the National Academy of Sciences
May 20, 2008

Species-Dependent Pharmacokinetics of CMX001. . .

   

BM Lampert, MR Almond, and LC Trost

47th Society of Toxicologists Annual Meeting
March 16-20, 2008
Seattle, Washington